These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24406113)

  • 1. Genomewide RNAi screen identifies protein kinase Cb and new members of mitogen-activated protein kinase pathway as regulators of melanoma cell growth and metastasis.
    Schönherr M; Bhattacharya A; Kottek T; Szymczak S; Köberle M; Wickenhauser C; Siebolts U; Saalbach A; Koczan D; Magin TM; Simon JC; Kunz M
    Pigment Cell Melanoma Res; 2014 May; 27(3):418-30. PubMed ID: 24406113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.
    Fagiani E; Giardina G; Luzi L; Cesaroni M; Quarto M; Capra M; Germano G; Bono M; Capillo M; Pelicci P; Lanfrancone L
    Cancer Res; 2007 Apr; 67(7):3064-73. PubMed ID: 17409413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using adenovirus armed short hairpin RNA targeting transforming growth factor β1 inhibits melanoma growth and metastasis in an ex vivo animal model.
    Tai KF; Wang CH
    Ann Plast Surg; 2013 Dec; 71 Suppl 1():S75-81. PubMed ID: 24284745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndecan-2 regulates melanin synthesis via protein kinase C βII-mediated tyrosinase activation.
    Jung H; Chung H; Chang SE; Choi S; Han IO; Kang DH; Oh ES
    Pigment Cell Melanoma Res; 2014 May; 27(3):387-97. PubMed ID: 24472179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression.
    Liu ZJ; Xiao M; Balint K; Smalley KS; Brafford P; Qiu R; Pinnix CC; Li X; Herlyn M
    Cancer Res; 2006 Apr; 66(8):4182-90. PubMed ID: 16618740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.
    Chetoui N; Sylla K; Gagnon-Houde JV; Alcaide-Loridan C; Charron D; Al-Daccak R; Aoudjit F
    Mol Cancer Res; 2008 Jan; 6(1):42-52. PubMed ID: 18234961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays.
    Nambiar S; Mirmohammadsadegh A; Doroudi R; Gustrau A; Marini A; Roeder G; Ruzicka T; Hengge UR
    Arch Dermatol; 2005 Feb; 141(2):165-73. PubMed ID: 15724012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genome-wide shRNA screen identifies GAS1 as a novel melanoma metastasis suppressor gene.
    Gobeil S; Zhu X; Doillon CJ; Green MR
    Genes Dev; 2008 Nov; 22(21):2932-40. PubMed ID: 18981472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Met is a potentially new therapeutic target for treatment of human melanoma.
    Puri N; Ahmed S; Janamanchi V; Tretiakova M; Zumba O; Krausz T; Jagadeeswaran R; Salgia R
    Clin Cancer Res; 2007 Apr; 13(7):2246-53. PubMed ID: 17404109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intertumoral heterogeneity of receptor-tyrosine kinases expression in human melanoma cell lines with different metastatic capabilities.
    Gutman M; Singh RK; Radinsky R; Bar-Eli M
    Anticancer Res; 1994; 14(5A):1759-65. PubMed ID: 7847808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant.
    Tsavachidou D; Coleman ML; Athanasiadis G; Li S; Licht JD; Olson MF; Weber BL
    Cancer Res; 2004 Aug; 64(16):5556-9. PubMed ID: 15313890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deacetylated GM3 promotes uPAR-associated membrane molecular complex to activate p38 MAPK in metastatic melanoma.
    Yan Q; Bach DQ; Gatla N; Sun P; Liu JW; Lu JY; Paller AS; Wang XQ
    Mol Cancer Res; 2013 Jun; 11(6):665-75. PubMed ID: 23525268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
    Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
    Recio JA; Merlino G
    Oncogene; 2002 Feb; 21(7):1000-8. PubMed ID: 11850817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells.
    Slipicevic A; Jørgensen K; Skrede M; Rosnes AK; Trøen G; Davidson B; Flørenes VA
    BMC Cancer; 2008 Sep; 8():276. PubMed ID: 18826602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
    Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
    Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of XRCC1 confers a metastatic phenotype to melanoma cells and is associated with poor survival in patients with melanoma.
    Bhandaru M; Martinka M; Li G; Rotte A
    Pigment Cell Melanoma Res; 2014 May; 27(3):366-75. PubMed ID: 24410901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma.
    Carson CC; Moschos SJ; Edmiston SN; Darr DB; Nikolaishvili-Feinberg N; Groben PA; Zhou X; Kuan PF; Pandey S; Chan KT; Jordan JL; Hao H; Frank JS; Hopkinson DA; Gibbs DC; Alldredge VD; Parrish E; Hanna SC; Berkowitz P; Rubenstein DS; Miller CR; Bear JE; Ollila DW; Sharpless NE; Conway K; Thomas NE
    Clin Cancer Res; 2015 May; 21(9):2167-76. PubMed ID: 25934889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.